Panagiotis Bouris

Panagiotis Bouris is a seasoned professional in the pharmaceutical and clinical research sectors, currently serving as a Medical Science Liaison at MSD Greece since June 2022. Prior experience includes roles as a Clinical Research Associate at Novo Nordisk from October 2020 to June 2022 and at Novartis from July 2019 to October 2020. Additionally, Panagiotis worked as a Clinical Research Associate at CreativePharmaServices between September 2018 and October 2020, and briefly contributed to quality control at Coca-Cola Hellenic Bottling Company in June 2008. Academically, Panagiotis holds a PhD in Oncology and Cancer Biology from the University of Patras, supplemented by visiting researcher positions at Uppsala University and Ludwig Cancer Research in 2016-2017. Educational background also includes a Master's Degree in Biochemistry and Molecular Biology and a Bachelor's degree in Chemistry, both from the University of Patras.